Safety, Tolerability and Efficacy of TV-1106 in Adults With Growth Hormone Deficiency
- Study Title
- Safety, Tolerability and Efficacy of Weekly TV-1106 in Adults With Growth Hormone Deficiency
- Teva Identifier
- TV1106-GHD-201 | 2012-004975-37
- ClinicalTrials.gov Identifier
- NCT01811576
- Study Status
- Completed
- Trial Condition(s)
- Growth Hormone Deficiency
- Interventions
- Drug: TV-1106 | Drug: Recombinant human growth hormone
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 23 Years to 65 Years
- Trial Duration
- March 31, 2013 - August 5, 2013
- Phase
- Phase 2
